Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new medicines for patients worldwide.
Catalent supports its partners in introducing 200 new products and manufacturing over 70 billion doses each year. We became a publicly traded company (NYSE: CTLT) in 2014 and have grown to become a vibrant community of approximately 17,500 employees.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Gilead Sciences est un laboratoire biopharmaceutique dont les recherches menées depuis plus de 35 ans ont conduit à des avancées médicales majeures, afin d’agir positivement sur la santé dans le monde. L’entreprise met à disposition des médicaments innovants pour prévenir et traiter des maladies potentiellement mortelles, dont le VIH, les hépatites virales, COVID-19 et le cancer. Basé en Californie, Gilead est présent dans plus de 35 pays.
Como companhia centrada nas ciências da vida, com mais de 150 anos em todo o mundo e 115 em Portugal, a Bayer trabalha para dar resposta a alguns dos maiores desafios mundiais como são a saúde e a alimentação.
Zentiva Romania is a producer of high-quality affordable medicines serving patients in Romania and Europe. With a dedicated team of more than 1250 people and 2 production sites in Bucharest, Zentiva is the leader in volumes of the total market and the leader in volumes and value of the generic medicines market in Romania. Our aspiration is that healthcare should be a right and not a privilege.
Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. We have a proven track record of success with two approved medicines in the U.S. and Europe and are significantly scaling our impact by advancing a broad pipeline of programs.
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. We work in over 50 countries and serve patients in more than 140 countries. Each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
Cada día, millones de pacientes, personal clínico y clientes en todo el mundo, confían en nuestro portafolio de productos y servicios, siendo líder en diagnóstico, cuidados críticos, nutrición clínica, cuidado renal, productos quirúrgicos y hospitalarios. Durante 65 años, hemos estado operando en la intersección donde las innovaciones que salvan y sostienen vidas se encuentran con los proveedores de la atención médica que lo hacen posible.
En Alcon, líder mundial en el cuidado de la visión, queremos mejorar la vida de las personas. Con más de 75 años de historia y dos divisiones de negocio, Cirugía y Vision Care, somos la mayor empresa mundial del sector.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.